Clinical trial
Five-Year Actively Controlled Clinical Trial in New Onset Juvenile Systemic…
NCT00336414 · Istituto Giannina Gaslini, Other · Withdrawn
Key facts
| NCT number | NCT00336414 |
|---|---|
| Title | Five-Year Actively Controlled Clinical Trial in New Onset Juvenile Systemic Lupus Erythematosus Nephritis |
| Official title | Five-Year Single-Blind, Phase III Effectiveness Randomised Actively Controlled Clinical Trial in New Onset Juvenile Systemic Lupus Erythematosus Nephritis: Oral Cyclophosphamide Versus High Dose Intravenous Cyclophosphamide Versus Intermediate Dose Intravenous Cyclophosphamide |
| Lead sponsor | Istituto Giannina Gaslini, Other |
| Status | Withdrawn |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Systemic Lupus Erythematosus Nephritis |
| Intervention type | Drug |
| Interventions | cyclophosphamide-prednisone-azathioprine |
| Enrollment | 0 |
| Start date | Jun 1, 2006 |
| Completion | Jun 1, 2007 |
| First posted | Jun 13, 2006 |
| Last update posted | Mar 20, 2018 |
| Countries | Italy |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: